Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
64th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE 2026) 8 - 10 September 2026

Baseline characteristics, treatment patterns and 12-month real-world effectiveness of somapacitan in patients with growth hormone deficiency (GHD): data from GloBE-Reg 

Authors :

Primoz Kotnik1,2, Malika Alimussina3, Suet Ching Chen4, Bradley S. Miller5, Alberto Pietropoli6, Dirk Schnabel7, Aristides Maniatis8, Abdulmoein Al-Agha9

Affiliations
View Details Hide Details
Download poster (.pdf)
Keywords
Rare Endocrine Disorder
Congress poster
Somapacitan